Search - tctmd.com

Displaying 181 - 200 of 261

Sort: Relevancy | Date

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

Presentation Fellows 2024

Case 3 & 4

Presenter: Yiannis S. Chatzizisis

April 14, 2024

Presentation Fellows 2024

Case 1 & 2

Presenter: Colin M. Barker

April 14, 2024

Presentation Fellows 2024

How and When to Use Intravascular Imaging in the Cath Lab

Presenter: Gary S. Mintz

April 13, 2024

Presentation Fellows 2024

How and When to Use Intracoronary Physiology in the Cath Lab

Presenter: Margaret B. McEntegart

April 13, 2024

Presentation Fellows 2024

Wire/Balloon/Catheter/Stent Technology: Fundamentals of Design and Use

Presenter: Margaret B. McEntegart

April 12, 2024

Presentation Fellows 2024

Coronary Angiography: Indications, Limitations, and Artifacts

Presenter: Chad Rammohan

April 12, 2024

Presentation Fellows 2024

Vascular Access and Management (Femoral, Radial, and Alternative): A Step-by-Step Approach

Presenter: Douglas E. Drachman

April 12, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Caitlin E. Cox

April 07, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Daily News

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Yael L. Maxwell

April 03, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Todd Neale

March 29, 2024

Advertisement

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Case 3 & 4

Case 1 & 2

How and When to Use Intravascular Imaging in the Cath Lab

How and When to Use Intracoronary Physiology in the Cath Lab

Wire/Balloon/Catheter/Stent Technology: Fundamentals of Design and Use

Coronary Angiography: Indications, Limitations, and Artifacts

Vascular Access and Management (Femoral, Radial, and Alternative): A Step-by-Step Approach

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

April 2024 Dispatch for the CV Team

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content